SIGA
SIGA TECHNOLOGIES INC
Key Financials
Operating Income
$23.7M
↓ 66.1%
Net Income
$23.3M
↓ 60.7%
Revenue
$94.6M
↓ 31.8%
EPS (Diluted)
$0.32
↓ 61.0%
Total Assets
$219.5M
↓ 10.2%
Cash & Equivalents
$155.0M
↓ 0.3%
Long-term Debt
$2.0M
↓ 49.7%
Shareholders' Equity
$198.8M
↓ 7.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| S-8 | 6/25/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SIGA |
| Company Name | SIGA TECHNOLOGIES INC |
| CIK | 1010086 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 212-672-9100 |